281,131 Shares in Marsh & McLennan Companies, Inc. $MRSH Acquired by Korea Investment CORP

Korea Investment CORP acquired a new stake in shares of Marsh & McLennan Companies, Inc. (NYSE:MRSH) in the 2nd quarter, HoldingsChannel reports. The institutional investor acquired 281,131 shares of the financial services provider’s stock, valued at approximately $46,856,000.

Several other hedge funds have also recently made changes to their positions in MRSH. Brighton Jones LLC boosted its position in Marsh & McLennan Companies by 51.2% during the fourth quarter. Brighton Jones LLC now owns 8,738 shares of the financial services provider’s stock worth $1,856,000 after purchasing an additional 2,960 shares during the period. Bison Wealth LLC boosted its holdings in shares of Marsh & McLennan Companies by 39.6% in the fourth quarter. Bison Wealth LLC now owns 3,064 shares of the financial services provider’s stock worth $651,000 after acquiring an additional 869 shares during the period. Glenview Trust co raised its stake in shares of Marsh & McLennan Companies by 10.8% during the 2nd quarter. Glenview Trust co now owns 3,897 shares of the financial services provider’s stock valued at $852,000 after purchasing an additional 379 shares during the period. Osterweis Capital Management Inc. boosted its stake in Marsh & McLennan Companies by 18,440.0% in the 2nd quarter. Osterweis Capital Management Inc. now owns 927 shares of the financial services provider’s stock worth $203,000 after purchasing an additional 922 shares during the period. Finally, Diversify Advisory Services LLC purchased a new position in Marsh & McLennan Companies during the 2nd quarter valued at about $1,307,000. 87.99% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

MRSH has been the topic of a number of recent analyst reports. Morgan Stanley increased their price target on shares of Marsh & McLennan Companies from $180.00 to $200.00 and gave the stock an “equal weight” rating in a report on Wednesday. Cantor Fitzgerald upped their target price on shares of Marsh & McLennan Companies from $210.00 to $218.00 and gave the stock an “overweight” rating in a report on Thursday, July 9th. Citigroup cut shares of Marsh & McLennan Companies from a “buy” rating to a “neutral” rating and set a $200.00 target price on the stock. in a research note on Wednesday, July 22nd. Piper Sandler cut their price target on shares of Marsh & McLennan Companies from $190.00 to $182.00 and set a “neutral” rating for the company in a report on Tuesday, May 26th. Finally, Mizuho upped their price target on shares of Marsh & McLennan Companies from $197.00 to $201.00 and gave the stock a “neutral” rating in a report on Wednesday, July 22nd. One research analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating, eleven have given a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $203.50.

Marsh & McLennan Companies Trading Up 1.0%

Shares of NYSE MRSH opened at $192.17 on Friday. The company has a quick ratio of 1.14, a current ratio of 1.14 and a debt-to-equity ratio of 1.22. The stock’s 50-day simple moving average is $179.88. The stock has a market capitalization of $91.71 billion, a price-to-earnings ratio of 23.49, a price-to-earnings-growth ratio of 2.75 and a beta of 0.59. Marsh & McLennan Companies, Inc. has a 12 month low of $156.60 and a 12 month high of $212.65.

Marsh & McLennan Companies (NYSE:MRSH) last posted its quarterly earnings data on Tuesday, July 21st. The financial services provider reported $2.96 earnings per share for the quarter, beating the consensus estimate of $2.89 by $0.07. Marsh & McLennan Companies had a net margin of 14.24% and a return on equity of 32.67%. The firm had revenue of $7.28 billion for the quarter. The business’s quarterly revenue was up 6.2% on a year-over-year basis. On average, analysts predict that Marsh & McLennan Companies, Inc. will post 10.43 earnings per share for the current year.

Marsh & McLennan Companies Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, August 14th. Stockholders of record on Thursday, July 23rd were issued a $0.99 dividend. This is an increase from Marsh & McLennan Companies’s previous quarterly dividend of $0.90. This represents a $3.96 annualized dividend and a dividend yield of 2.1%. The ex-dividend date was Thursday, July 23rd. Marsh & McLennan Companies’s dividend payout ratio (DPR) is presently 48.41%.

Insider Buying and Selling

In other Marsh & McLennan Companies news, Director Lloyd M. Yates sold 12,000 shares of Marsh & McLennan Companies stock in a transaction that occurred on Thursday, July 23rd. The stock was sold at an average price of $175.65, for a total value of $2,107,800.00. Following the transaction, the director directly owned 12,001 shares of the company’s stock, valued at $2,107,975.65. The trade was a 50.00% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Martin South sold 7,100 shares of the business’s stock in a transaction that occurred on Tuesday, July 28th. The shares were sold at an average price of $189.99, for a total value of $1,348,929.00. Following the completion of the sale, the insider owned 16,632 shares of the company’s stock, valued at $3,159,913.68. The trade was a 29.92% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 36,469 shares of company stock worth $6,291,345 in the last ninety days. Corporate insiders own 0.38% of the company’s stock.

Marsh & McLennan Companies Company Profile

Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.

The firm operates through several well-known subsidiaries and business units that specialize in distinct services.